AU2001278804A1 - 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients - Google Patents

5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients

Info

Publication number
AU2001278804A1
AU2001278804A1 AU2001278804A AU7880401A AU2001278804A1 AU 2001278804 A1 AU2001278804 A1 AU 2001278804A1 AU 2001278804 A AU2001278804 A AU 2001278804A AU 7880401 A AU7880401 A AU 7880401A AU 2001278804 A1 AU2001278804 A1 AU 2001278804A1
Authority
AU
Australia
Prior art keywords
same
fluorocytosine
deoxy
derivatives
active ingredients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278804A
Other languages
English (en)
Inventor
Sung-Min Cho
Ji-Young Kim
Kwan-Hee Kim
Youn-Chul Kim
Kyeongho Lee
Moon-Jong Noh
Ho-Jin Park
Young-Seok Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kolon Industries Inc
Original Assignee
Kolon Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020000046179A external-priority patent/KR100730768B1/ko
Priority claimed from KR1020010044193A external-priority patent/KR20030009649A/ko
Application filed by Kolon Industries Inc filed Critical Kolon Industries Inc
Publication of AU2001278804A1 publication Critical patent/AU2001278804A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2001278804A 2000-08-09 2001-08-08 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients Abandoned AU2001278804A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR1020000046179A KR100730768B1 (ko) 2000-08-09 2000-08-09 5'-데옥시-n-알킬옥시카르보닐-5-플루오로사이토신-5'-카르복실산 및 그 유도체와 이들의 제조방법
KR0046179 2000-08-09
KR1020010044193A KR20030009649A (ko) 2001-07-23 2001-07-23 Ν-알키닐옥시카르보닐-5-플루오로시토신 유도체, 그제조방법 및 이를 유효성분으로 포함하는 항암제
KR0144193 2001-07-23
PCT/KR2001/001351 WO2002011668A2 (en) 2000-08-09 2001-08-08 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients

Publications (1)

Publication Number Publication Date
AU2001278804A1 true AU2001278804A1 (en) 2002-02-18

Family

ID=26638291

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278804A Abandoned AU2001278804A1 (en) 2000-08-09 2001-08-08 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients

Country Status (5)

Country Link
EP (1) EP1311524A2 (enrdf_load_stackoverflow)
JP (1) JP2004505899A (enrdf_load_stackoverflow)
CN (1) CN1446225A (enrdf_load_stackoverflow)
AU (1) AU2001278804A1 (enrdf_load_stackoverflow)
WO (1) WO2002011668A2 (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008010571A1 (fr) * 2006-07-21 2008-01-24 Taiho Pharmaceutical Co., Ltd. Composé nucléosidique de 2'cyanopyrimidine
CN101993464B (zh) * 2009-08-19 2014-07-23 成都弘达药业有限公司 一种卡培他滨的制备方法
CN103897004B (zh) * 2012-12-27 2017-05-31 鲁南制药集团股份有限公司 一种卡培他滨的合成方法
SG11201810947PA (en) * 2016-06-28 2019-01-30 Cellix Bio Private Ltd Compositions and methods for the treatment of cancer
CN110831605A (zh) * 2017-04-26 2020-02-21 托马斯·I.·卡尔曼 多靶标的核苷衍生物
BR112021001652A2 (pt) * 2018-08-03 2021-05-04 Cellix Bio Private Limited composto e composição farmacêutica

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968914A (en) * 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US6642245B1 (en) * 1990-02-01 2003-11-04 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane

Also Published As

Publication number Publication date
JP2004505899A (ja) 2004-02-26
WO2002011668A2 (en) 2002-02-14
WO2002011668A3 (en) 2002-04-18
EP1311524A2 (en) 2003-05-21
CN1446225A (zh) 2003-10-01

Similar Documents

Publication Publication Date Title
HUP9802822A3 (en) Halobenzimidazol derivatives, intermediates, preparation thereof and microbocide compositions containing these compounds as active ingredients
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2268301A (en) Novel urea compounds, compositions and methods of use and preparation
AU4949800A (en) 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
PL349448A1 (en) Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
AU2001269198A1 (en) Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
AU2001235737A1 (en) Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
CA2361402A1 (en) Bis-sulfonamides
EP2017269A3 (en) A pharmaceutical compodition comprising form II crystalline Ritonavir and a preparation thereof
HUP9900365A3 (en) N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients
AU2841199A (en) Novel bis-benzamide derivatives, method for making same pharmaceutical compositions containing them and use thereof as medicine
AU2001220437A1 (en) Degradable crosslinkers, compositions therefrom, and methods of their preparation and use
AU2001278804A1 (en) 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
HUP9700983A3 (en) 1,4-diaryl-2-fluoro-2-butene derivatives, intermediates, preparation and use thereof, insecticide and acaricide compositions containing these compounds as active ingredients
AU2001252711A1 (en) Aqueous-prodrug compound comprising moiety of paclitxel or derivatives thereof, method of preparing same and pharmaceutical composition comprising same
HUP9901104A3 (en) Pyrazole-4-yl-hetaroyl derivatives, preparation and use thereof, herbicide compositions containing these compounds as active ingredients
AU6866500A (en) Chromone derivatives, process for the preparation of the same and uses thereof
EP1059304A4 (en) NOVEL POLYSACCHARIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITIONS CONTAINING THESE NEW DERIVATIVES AS ACTIVE INGREDIENT
HUP9802345A3 (en) Pyrazol-4-yl-benzoyl derivatives, preparation and use thereof, herbicide compositions containing these compounds as active ingredients
AU2001248456A1 (en) Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides
AU1556000A (en) Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
AU4845196A (en) 2-sulfinylnicotinamide derivatives, intermediate thereof, process for producing 2-sulfinylnicotinamide derivatives, and medicinal composition containing the same as active ingredient
HUP0204444A3 (en) Phenyl- and pyridyl-tetrahydro-pyridines, process for their preparation and pharmaceutical compositions containing them
HU9700437D0 (en) Substituted thiophenyl-alkenyl-carboxylic-acid-guanidid-derivatives, their production, their use as active component of pharmaceutical compositions, and pharmaceutical compositions containing them